Proton Intelligence is developing a real-time, on-demand potassium monitoring wearable that enables precise management of hyperkalemia in patients with chronic kidney disease. This technology addresses the critical need for continuous potassium level tracking to prevent heart attacks and improve patient safety during treatment.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hyperkalemia, a condition of elevated potassium levels, affects millions of Americans with chronic kidney disease and can lead to heart attacks. Current methods for monitoring potassium levels are infrequent and do not provide real-time data, hindering precise management and posing risks during treatment.
Solution
Proton Intelligence is developing a wearable device for real-time, on-demand potassium monitoring. This technology aims to provide clinicians with continuous data to safely and precisely manage hyperkalemia in patients with chronic kidney disease. The device enables timely intervention and personalized treatment adjustments based on immediate potassium levels, reducing the risk of complications.
Target Audience
The primary target audience includes clinicians and patients with chronic kidney disease at risk of hyperkalemia.
Features
- Non-invasive, wearable sensor for continuous potassium monitoring
- Real-time data transmission to clinicians
- On-demand potassium level readings